The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drugs

• Publication date

  2014-07-18

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s40265-014-0254-0PMID 25034359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐term efficacy and safety of fluphenazine in patients with Tourette syndrome

  2014cited by this paper
• Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

  2014cited by this paper
• Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort†

  2014cited by this paper
• Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture

  2013cited by this paper
• Trials of Pharmacological Interventions for Tourette Syndrome: A Systematic Review

  2013cited by this paper
• Pharmacological treatment of Gilles de la Tourette syndrome.

  2013cited by this paper
• Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

  2013cited by this paper
• Functional Neuroimaging Investigations of Motor Networks in Tourette Syndrome

  2013cited by this paper
• The Impact of Tourette Syndrome in Adults: Results from the Tourette Syndrome Impact Survey

  2013cited by this paper
• The pharmacology of Tourette syndrome

  2013cited by this paper
• Current controversies on the role of behavior therapy in Tourette syndrome

  2013cited by this paper
• Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Genetic susceptibility and neurotransmitters in Tourette syndrome.

  2013cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.

  2013cited by this paper
• Systematic review: Pharmacological treatment of tic disorders – Efficacy of antipsychotic and alpha-2 adrenergic agonist agents

  2013cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with tic disorders.

  2013cited by this paper
• A cluster analysis of tic symptoms in children and adults with Tourette syndrome: clinical correlates and treatment outcome.

  2013cited by this paper
• Genome-wide association study of obsessive-compulsive disorder

  2013cited by this paper
• The future of tic disorder treatment

  2013cited by this paper
• Support of the histaminergic hypothesis in Tourette Syndrome: association of the histamine decarboxylase gene in a large sample of families

  2013cited by this paper
• Pharmacological treatment of tic disorders and Tourette Syndrome.

  2013cited by this paper
• Immune-mediated animal models of Tourette syndrome.

  2013cited by this paper
• The prognosis of Tourette syndrome: implications for clinical practice.

  2012cited by this paper
• From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS (Pediatric Acute-onset Neuropsychiatric

  2012cited by this paper
• Olanzapine treatment for tics in an adult woman with severe tourette syndrome.

  2012cited by this paper
• Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort

  2012cited by this paper
• CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations.

  2012cited by this paper
• Treatment practices in Tourette syndrome: the European perspective.

  2012cited by this paper
• Prevalence of Tourette Syndrome and Chronic Tics in the Population-Based Avon Longitudinal Study of Parents and Children Cohort

  2012cited by this paper
• Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Behavioural Therapy, Deep Brain Stimulation, and Transcranial Magnetic Stimulation

  2012cited by this paper
• Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy

  2012cited by this paper
• Tolerability profile of aripiprazole in patients with Tourette syndrome

  2012cited by this paper
• Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months

  2012cited by this paper
• Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.

  2012cited by this paper
• Prevalence of tic disorders: a systematic review and meta-analysis.

  2012cited by this paper
• Cohort Profile: The ‘Children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children

  2012cited by this paper
• Genome-wide association study of Tourette Syndrome

  2012cited by this paper
• Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study

  2012cited by this paper
• Aripiprazole for the Treatment of Tourette Syndrome: A Case Series of 100 Patients

  2012cited by this paper
• Randomized trial of behavior therapy for adults with Tourette syndrome.

  2012cited by this paper
• Neurobiology of Tourette Syndrome: Current Status and Need for Further Investigation

  2011cited by this paper
• The genetics of Tourette disorder.

  2011cited by this paper
• Recent advances in Tourette syndrome.

  2011cited by this paper
• European clinical guidelines for Tourette Syndrome and other tic disorders

  2011cited by this paper
• Paliperidone extended-release: does it have a place in antipsychotic therapy?

  2011cited by this paper
• Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome

  2011cited by this paper
• The role of impulse control disorders in Tourette syndrome: an exploratory study.

  2011cited by this paper
• European clinical guidelines for Tourette Syndrome and other tic disorders. Part III: behavioural and psychosocial interventions

  2011cited by this paper
• Newer oral atypical antipsychotic agents: a review.

  2011cited by this paper
• Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome

  2011cited by this paper
• Paroxysmal limb dyskinesia induced by weight: An unusual case of cortical reflex seizures

  2011cited by this paper
• Gilles de la Tourette syndrome: the complexities of phenotype and treatment.

  2011cited by this paper
• Tolerability of quetiapine in children and adolescents with Tourette's syndrome.

  2011cited by this paper
• European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment

  2011cited by this paper
• Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

  2011cited by this paper
• Behavior therapy for children with Tourette disorder: a randomized controlled trial.

  2010cited by this paper
• Tourette's syndrome in adults

  2010cited by this paper
• The Immunobiology of Tourette's Disorder, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus, and Related Disorders: A Way Forward

  2010cited by this paper
• Internalizing Versus Externalizing Comorbidity: Neural Circuit Hypothesis

  2010cited by this paper
• L-histidine decarboxylase and Tourette's syndrome.

  2010cited by this paper
• Treatment of Tics and Tourette Syndrome

  2010cited by this paper
• Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Pilot Study in China

  2010cited by this paper
• Aripiprazole for the Treatment of Adolescent Tourette’s Syndrome

  2010cited by this paper
• Immunopathogenic mechanisms in tourette syndrome: A critical review

  2009cited by this paper
• Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients

  2009cited by this paper
• The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder.

  2009cited by this paper
• Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007.

  2009cited by this paper
• Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study

  2009cited by this paper
• Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

  2009cited by this paper
• Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder.

  2009cited by this paper
• Pimozide for tics in Tourette's syndrome.

  2009cited by this paper
• Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.

  2009cited by this paper
• The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective.

  2009cited by this paper
• Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.

  2009cited by this paper
• Aripiprazole Treatment of Children and Adolescents with Tourette Disorder or Chronic Tic Disorder

  2008cited by this paper
• Exacerbation of tics secondary to clozapine therapy.

  2008cited by this paper
• Aripiprazole in Children and Adolescents with Tourette Disorder with and without Explosive Outbursts

  2008cited by this paper
• Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia

  2008cited by this paper
• Obsessional jealousy: unusual presentation.

  2008cited by this paper
• Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?

  2008cited by this paper
• Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome

  2008cited by this paper
• The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies.

  2008cited by this paper
• Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette Syndrome

  2008cited by this paper
• Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

  2008cited by this paper
• Habits, rituals, and the evaluative brain.

  2008cited by this paper
• A three-country comparison of psychotropic medication prevalence in youth

  2008cited by this paper
• The influence of contextual factors on tic expression in Tourette's syndrome: a review.

  2008cited by this paper
• Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome.

  2007cited by this paper
• [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

  2007cited by this paper
• Die Benzamide Tiaprid, Sulpirid und Amisulprid in der Therapie des Tourette-Syndroms

  2007cited by this paper
• Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette’s Syndrome

  2007cited by this paper
• Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study.

  2007cited by this paper
• Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis.

  2007cited by this paper
• Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.

  2007cited by this paper
• Time trends in reported diagnoses of childhood neuropsychiatric disorders: a Danish cohort study.

  2007cited by this paper
• Phenomenology of tics and natural history of tic disorders.

  2006cited by this paper
• Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response.

  2006cited by this paper
• Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults

  2006cited by this paper
• A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole

  2006cited by this paper

• Mechanistic insights and therapeutic approaches in tic disorders: The distinctive role of ethnomedicine and modern medical interventions.

  2025cites this paper
• Pain in Tourette Syndrome: A Comprehensive Review

  2024cites this paper
• Pharmacological Treatment of Tourette Disorder in Children

  2024cites this paper
• Diagnosing and Treating Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections.

  2024cites this paper
• Comparison of children and adults in deep brain stimulation for Tourette Syndrome: a large-scale multicenter study of 102 cases with long-term follow-up

  2024cites this paper
• Deep brain stimulation alleviates tics in Tourette syndrome via striatal dopamine transmission

  2023cites this paper
• Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.

  2023cites this paper
• Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature

  2022cites this paper
• SIMULTANEOUS DETERMINATION OF FLUPENTIXOL AND NORTRIPTYLINE HCl USING RP-HPLC WITH PDA DETECTOR

  2022cites this paper
• Current and emerging pharmacotherapeutic strategies for Tourette syndrome

  2022cites this paper
• Current understanding of the genetics of tourette syndrome

  2022cites this paper
• Tourette's Disorder

  2021cites this paper
• Elevated Expression of SLC6A4 Encoding the Serotonin Transporter (SERT) in Gilles de la Tourette Syndrome

  2021cites this paper
• Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study

  2021cites this paper
• A Comprehensive Review of Tic Disorders in Children

  2021cites this paper
• Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review

  2021cites this paper
• European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment

  2021cites this paper
• Assessment of Tic Severity

  2020cites this paper
• Other Tic-Suppressing Medications

  2020cites this paper
• Tourette’s disorder in children and adolescents

  2020cites this paper
• Current pharmacotherapy for tic disorders

  2020cites this paper
• Pediatric Prevention: Tic Disorders.

  2020cites this paper
• A critical narrative review of medical cannabis in pediatrics beyond epilepsy, part II: neurodevelopmental, movement, and pain disorders

  2020cites this paper
• Pharmacological Treatment of Tics

  2020cites this paper
• [Tourette syndrome: Research challenges to improve clinical practice].

  2020cites this paper
• Further reading

  2020cites this paper
• Index

  2020cites this paper
• Guidelines Based on Expert Survey and Consensus

  2020cites this paper
• Introduction: The Long and Winding Road to Tourette Syndrome

  2020cites this paper
• Second-Generation Anti-dopaminergic Medications

  2020cites this paper
• First-Generation Anti-dopaminergic Medications

  2020cites this paper
• Guidelines Based on Systematic Literature Review and Meta-analysis

  2020cites this paper
• Alpha-2 Adrenergic Medications

  2020cites this paper
• Evaluation and Differential Diagnosis of Tics and Related Disorders

  2020cites this paper
• Gilles de la Tourette syndrome: an update on the treatment of paediatric patients

  2019influential citation
• Executive Function Disorders in Pediatric Neuropsychology: Attention-Deficit/Hyperactivity Disorder and Tourette Disorder

  2019cites this paper
• Pallidal deep brain stimulation combined with capsulotomy for Tourette's syndrome with psychiatric comorbidity.

  2019cites this paper
• Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account.

  2018cites this paper
• Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis

  2018cites this paper
• Treatment Resistance in Attention-Deficit/Hyperactivity Disorder

  2018cites this paper
• Sensory aspects of Tourette syndrome

  2018influential citation
• Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics

  2018cites this paper
• Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents.

  2018cites this paper
• Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome

  2018influential citation
• Biological Models and Treatments for Obsessive‐Compulsive Related Disorders for Adults

  2017cites this paper
• Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I—Psychiatric and Behavioral Interventions

  2017cites this paper
• The Bird Dancer: Social Rejection and Social Suffering

  2017cites this paper
• Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis

  2016cites this paper
• Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders

  2016cites this paper
• Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.

  2016cites this paper
• Challenges and Promises of Pediatric Psychopharmacology.

  2016cites this paper
• Biological treatments for obsessive-compulsive and related disorders

  2015cites this paper
• Ziprasidone Monotherapy for Tourette Syndrome with Comorbid ADHD

  2015cites this paper